Specifically, reduced ACAT1‐catalysed CE synthesis leads to free cholesterol accumulation, decreased LDL receptor levels and reduced essential fatty acid uptake, thereby impairing cell proliferation and tumour growth in vivo. The gene discussed is ACAT1; the disease is neoplasm.